Original Articles

Clinical Review of Periorbital Capillary Hemangioma of Infancy

Assad Jalil, MRCOphth; Anna Maino, FRCOphth; Rajan Bhojwani, FRCOphth; Mark Vose, FRCOphth; Jane Ashworth, PhD, FRCOphth; I. C. Lloyd, FRCOphth; Susmito Biswas, FRCOphth

  • Journal of Pediatric Ophthalmology and Strabismus
  • July/August 2011 - Volume 48 · Issue 4: 218-225
  • DOI: 10.3928/01913913-20100719-04
Rights and Permissions

Abstract

Purpose:

To explore the role of intralesional steroid injections (ILSI) and oral steroids in the management of periocular hemangioma of infancy (HOI).

Methods:

In this retrospective study, treatment options studied were observation, ILSI, and oral steroids. All children received adjunctive amblyopia treatment if required. The main indications for treatment were cosmetic, worsening astigmatism, and visual axis obscuration. Success was defined as complete HOI regression before the age of 5 years (cosmetic group), reduction of astigmatism of at least 1 diopter cylinder (DC) (astigmatism group), or no evidence of amblyopia at the last follow-up (visual axis obscuration group).

Results:

Twenty-four of 41 children (58.5%) had amblyopia at presentation. Eighteen children formed the observation group, 17 children received ILSI, and 6 children received oral steroids. Successful outcome was achieved in all except 2 patients in the cosmetic group and 6 of 7 in the visual axis obscuration group. Mean astigmatic correction of all cases was 1.65 ± 1.34 DC before treatment and 0.91 ± 1.17 DC after treatment, the change being statistically significant ( P < .001).

Conclusion:

Observation appears to be a highly effective strategy if coupled with amblyopia therapy, especially for mild cases. Intralesional and oral steroids appear to be equally effective for lesions requiring treatment, but their exact role cannot be clearly determined in the presence of a spontaneously resolving lesion.

AUTHORS
From The University of Manchester, Manchester Academic Health Science Centre, Manchester Royal Eye Hospital, Manchester, United Kingdom.

Supported by the NIHR Manchester Biomedical Research Centre.

Presented as a poster at the American Association for Pediatric Ophthalmology & Strabismus annual meeting, April 2–6, 2008, Washington, DC.

The authors have no financial or proprietary interest in the materials presented herein.

Address correspondence to Assad Jalil, MRCOphth, Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WH, United Kingdom. E-mail: assadjalil@hotmail.com

Received: March 14, 2010
Accepted: May 03, 2010
Posted Online: July 22, 2010

doi: 10.3928/01913913-20100719-04

Healio is intended for health care provider use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will Healio be used for medical advice to patients.

[X]